Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 19/10/19981 min de lecture
Determination That Sutilains Ointment USP Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its determination that sutilains ointment USP (Travase Ointment) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDA's) for sutilains ointment USP.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →